Related Experiment Video

Updated: Aug 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

The future of neonatal therapeutic drug monitoring

G P Giacoia1

  • 1Department of Pediatrics, University of Oklahoma, College of Medicine, Tulsa.

Therapeutic Drug Monitoring
|July 1, 1990
PubMed

Insights

Therapeutic drug monitoring (TDM) is crucial for neonates, but factors like physiological instability and high costs can limit its use. Developing specialized pharmacokinetic services is essential for optimizing TDM in sick infants.

Area of Science:

  • Neonatal pharmacology
  • Clinical toxicology
  • Pharmacokinetics

Background:

  • Therapeutic drug monitoring (TDM) is integral to clinical decision-making in neonatal intensive care.
  • Sick neonates exhibit physiological instability, complicating drug concentration interpretation.
  • Increased potential for adverse drug events necessitates careful monitoring in this population.

Purpose of the Study:

  • To review factors influencing the expansion or restriction of neonatal TDM.
  • To advocate for specialized pharmacokinetic services tailored to neonates.
  • To highlight the unique challenges in TDM for very low birth weight infants.

Main Methods:

  • Literature review of factors affecting neonatal TDM.
  • Analysis of pharmacokinetic considerations in unstable neonatal populations.
  • Discussion of challenges and future directions for neonatal TDM.

Main Results:

  • Neonatal TDM faces limitations due to patient instability and non-steady-state drug concentrations.
  • High costs, technology expenses, and ethical/political issues impact TDM accessibility for very low birth weight infants.
  • The need for tailored pharmacokinetic services to address unique neonatal needs is evident.

Conclusions:

  • Optimizing neonatal TDM requires addressing physiological complexities and developing specialized services.
  • Pharmacokinetic expertise is critical for accurate drug concentration interpretation in neonates.
  • Future advancements in neonatal TDM are contingent upon overcoming economic and logistical barriers.

More Related Videos

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates05:58

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

Published on: September 6, 2017

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...